↓ Skip to main content

Dove Medical Press

Topiramate in the prevention and treatment of migraine: efficacy, safety and patient preference

Overview of attention for article published in Neuropsychiatric Disease and Treatment, December 2009
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

news
1 news outlet
twitter
1 X user
wikipedia
1 Wikipedia page

Citations

dimensions_citation
32 Dimensions

Readers on

mendeley
140 Mendeley
Title
Topiramate in the prevention and treatment of migraine: efficacy, safety and patient preference
Published in
Neuropsychiatric Disease and Treatment, December 2009
DOI 10.2147/ndt.s6459
Pubmed ID
Authors

Steffen Naegel, Mark Obermann

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 140 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
India 1 <1%
Germany 1 <1%
Unknown 138 99%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 23 16%
Researcher 21 15%
Student > Master 16 11%
Student > Ph. D. Student 10 7%
Other 8 6%
Other 24 17%
Unknown 38 27%
Readers by discipline Count As %
Medicine and Dentistry 46 33%
Agricultural and Biological Sciences 10 7%
Pharmacology, Toxicology and Pharmaceutical Science 10 7%
Neuroscience 8 6%
Psychology 6 4%
Other 18 13%
Unknown 42 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 June 2022.
All research outputs
#2,655,377
of 25,371,288 outputs
Outputs from Neuropsychiatric Disease and Treatment
#346
of 3,132 outputs
Outputs of similar age
#12,258
of 176,932 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#2
of 5 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,132 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 176,932 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 5 others from the same source and published within six weeks on either side of this one. This one has scored higher than 3 of them.